Business Development, USG

Valthos Inc.

Valthos builds next-generation biodefense. Of all AI applications, biotechnology has the highest upside and most catastrophic downside. The world is approaching near-universal access to powerful, dual-use biotechnologies capable of eliminating disease or creating it.

At Valthos, our mission to make sure the technologies to characterize biological threats and update our medical countermeasures advances faster than the threats we face. Our team of computational biologists and software engineers develop, evaluate, and deploy frontier AI methods in software to support critical workflows in government and pharmaceutical development. The AI systems we develop today will accelerate our ability to respond to threats and lay the groundwork for the adaptive, precision therapeutics of tomorrow.

Our founding team comes from Palantir, DeepMind, the Broad Institute, and the Arc Institute, and we are supported by world class investors from OpenAI, Lux Capital, and Founders Fund.

The Role

Valthos is building a platform to support a wide range of stakeholders in government and pharma, with a specific focus on strengthening biodefense programs in the Department of War (DoW).

We are seeking an experienced, highly skilled leader to build and drive the Valthos business development for US Government. In this role, you will develop an end-to-end strategy for government acquisitions, from initial outreach and proposal development through negotiation and contract closure. You will use your experience and network to identify and map out stakeholders, programs, and budgets; work closely with Valthos technical teams to translate mission needs to product roadmap and position our product to stakeholders; and define the short- and long-term strategy for Valthos in the US Government. More broadly, you will be a key voice in shaping how stakeholders across government and industry think about the future of biodefense.

We will expect you to build out a team as we grow and bring in the necessary consultants or lobbyists to achieve your strategy. While the initial focus will be DoW, we are looking for someone who can communicate across departments, understanding what programs exist today and what kind of interagency work can be shaped for the future.

Preferred Experience

• Prior contracting and acquisitions work in the Federal sector

• Familiarity with DoW Program/Budget process, proposal processes, and lifecycle of a contract

• Experience in writing policy opinions and engaging in thought leadership activities

• Optional but not required: Existing network within the biodefense community within DoW, HHS, DHS and private sector pharma